Astellas Pharma | 4503 - Net Income


Astellas Pharma reported JPY99.85B in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
Astellas Pharma JPY 99.85B 41.98B Sep/2026
Chugai Pharma JPY 143.55B 27.22B Sep/2026
Daiichi Sankyo JPY 82.9B 14.26B Sep/2026
Eisai JPY 11.69B 6.55B Sep/2026
Kyowa Hakko Kirin JPY 21.06B 2.47B Sep/2026
M3 JPY 10.92B 1.85B Sep/2026
Otsuka Holdings JPY 106.49B 10.77B Sep/2026
Shionogi JPY 21.85B 75.85B Sep/2026
Sumitomo Dainippon JPY 21.24B 4.24B Sep/2026
Takeda JPY 192.43B 79.23B Sep/2026
Terumo JPY -15.81B 86.24B Sep/2026